BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Short (1M)
Elara Capital Recommends 'Reduce' On Dr Reddy's
According to Elara Capital, Dr Reddy's Laboratories has faced challenging times on the revenue front over the past two years, although it has done well to rein in cost. The company has a high-value ANDA pipeline, but the timing of approvals remains uncertain, the brokerage adds.